ValuEngine, Inc., Feb 2012, Pages: 12
Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Our three models: Valuation Model, Forecast
ValuEngine, Inc., Feb 2012, Pages: 12
Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Our three models: Valuation Model, Forecast
ValuEngine, Inc., Feb 2012, Pages: 12
Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Our three models: Valuation Model, Forecast
ValuEngine, Inc., Feb 2012, Pages: 12
With this valuationreport, you too, as an individual investor or investment professional, can have access to the same tools used by equity fund and portfolio managers as they deal with billions
Takeda Pacific, Aug 2010, Pages: 150
and personalized medicine. This business report analyzes key market segments such lifescience research tools, diagnostics and therapeutics.
Many people already know about DNA, genes and the human genome. The DNA
Wright Investors' Service, Feb 2012, Pages: 41
Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for RBC LifeSciences, Inc. are the Company Description, Recent
Wright Investors' Service, Feb 2012, Pages: 40
and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Advanced LifeSciences
Wright Investors' Service, Feb 2012, Pages: 42
Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Caliper LifeSciences, Inc. are the Company Description, Recent
Wright Investors' Service, Feb 2012, Pages: 41
Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Bioniche LifeSciences Inc. are the Company Description, Recent
Wright Investors' Service, Feb 2012, Pages: 42
Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Prometic LifeSciences Inc. are the Company Description, Recent
Wright Investors' Service, Feb 2012, Pages: 40
and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Equator LifeScience Berhad
Fuji-Keizai USA, Inc., Jan 2009, Pages: 148
This report presents information about the quickly emerging worldwide epigenetics market. This important lifescience market includes key product areas that will have a powerful impact on current
Wright Investors' Service, Feb 2012, Pages: 42
Zentaris Incorporated versus Bioniche LifeSciences Inc., Warnex Inc and Afexa LifeSciences Incorporated. The comparative analysis of these companies compares Sales (sales, sales growth and sales per
iCD Research, Feb 2012, Pages: 34
Synopsis
ICD Research's "CK LifeSciences Int'l., (Holdings) Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company
iCD Research, Feb 2012, Pages: 34
'l., (Holdings) Inc..
ICD Research's "CK LifeSciences Int'l., (Holdings) Inc. .: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented
Business Insights, July 2010, Pages: 133
Corporate Venture Capital (CVC) funds
Emerging role of CVC in LifeSciences
Strategic motivations
Novartis Venture Fund
Novo A/S, Denmark
Independent venture capital funds
SV LifeSciences
Investment
Wright Investors' Service, Feb 2012, Pages: 42
employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for SeraCare LifeSciences, Inc
Wright Investors' Service, Feb 2012, Pages: 41
and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for CK LifeSciences Intl
Wright Investors' Service, Feb 2012, Pages: 40
employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for AMS LifeScience Company Limited
